Bath & Body Works, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BBWI research report →
Range $19 – $26
Price Chart
About the company
Bath & Body Works, Inc. operates as a specialty retailer of personal care and home fragrance products. The company offers body and home fragrances, including 3-wick candles, home fragrance diffusers, fine fragrance mists, eau de parfum, body wash, hand soaps, body lotions, and body creams, as well as sanitizer and other products.
- CEO
- Daniel Heaf
- IPO
- 1982
- Employees
- 60,735
- HQ
- Columbus, OH, US
Get TickerSpark's AI analysis on BBWI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $3.96B
- P/E
- 5.67
- Fwd P/E
- 7.43
- PEG
- -0.73
- P/S
- 0.55
- P/B
- -3.51
- EV/EBITDA
- 5.51
- Div Yield
- 4.07%
- Gross Margin
- 43.19%
- Op Margin
- 15.85%
- Net Margin
- 10.03%
- ROE
- -52.38%
- ROIC
- 24.40%
Latest fiscal year · YoY change
- Revenue
- $7.29B-0.2%
- Gross Profit
- $3.19B-1.4%
- Op Income
- $1.13B
- Net Income
- $649.00M-18.7%
- EPS
- $3.07-15.2%
- OCF Growth
- +24.4%
- FCF Growth
- +31.1%
- 52W High
- $32.32
- 52W Low
- $14.28
- 50D MA
- $20.33
- 200D MA
- $20.28
- Beta
- 1.38
- RSI (14)
- 49
- Avg Volume
- 5.73M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Bath & Body Works beat Q1 expectations, but management said underlying demand remains pressured and the recovery will be gradual through 2026 and into 2027.· May 27, 2026
- Q1 net sales fell 3.2% to $1.4 billion, and adjusted EPS was $0.32, both ahead of expectations but below the company’s desired standard.
- Gross margin pressure came from tariffs, inflation and crude oil, while body care was the biggest drag, declining mid-teens.
- Management reaffirmed full-year 2026 guidance, signaling no change to the company’s view despite weak underlying trends.
- Early signs of the consumer-first strategy included stronger results from new moisturizing/revitalizing soaps, White Barn Neutrals, Amazon, and international growth.
- Eva Boratto will depart as CFO; the company said Tom will serve as interim CFO while a search is underway.
First quarter net sales were $1.4 billion, down 3.2% year over year and ahead of guidance. Adjusted EPS was $0.32, also ahead of expectations. Adjusted gross profit rate was 42.7%, down 270 basis points, and adjusted operating income was $151 million, or 11% of net sales. Adjusted SG&A rate was 31.7%, up 100 basis points year over year. For the full year 2026, the company reaffirmed net sales guidance of down 4.5% to down 2.5% and adjusted EPS guidance of $2.40 to $2.65. For Q2, it expects net sales down 5% to down 3% and adjusted EPS of $0.20 to $0.25, with gross profit rate around 40% and SG&A rate around 31.8%.
Daniel Heaf framed the quarter as consistent with the early phase of a multiyear transformation, saying the company is moving from strategy to execution and beginning to see early proof points. He emphasized investment in innovation, brand rebuilding, marketplace execution and store/digital improvements, but also said the underlying business remains pressured and the company is not calling an inflection yet. His tone was confident but measured, with repeated comments that progress should become more visible in the back half of 2026 and into 2027.
Eva Boratto said Q1 adjusted gross profit rate was 42.7%, down 270 basis points, with merchandise margin down 210 basis points mainly from tariffs, inflation, crude oil and category mix. She noted adjusted SG&A dollars were flat and the rate was 31.7%, helped by incremental cost savings and timing, while adjusted operating income was $151 million and adjusted EPS was $0.32. On cash allocation, she said Q1 capex was $49 million, dividends returned $40 million, and the company redeemed $284 million of January 2027 notes; for 2026, capex is expected to be about $270 million and free cash flow about $600 million, including a $66 million after-tax litigation benefit. She also said guidance does not include share repurchases, tariff refunds, or a benefit from potential tariff refunds, and assumes elevated energy prices and roughly neutral tariff/inflation pressure year over year.
Analysts focused on body care weakness, Amazon, tariffs, promotional strategy, and whether sales inflection has been pushed into 2027. Management said body care underperformed because of Disney assortment mix and an overly reduced everyday luxury assortment, but that inventory has been restored with 10 fragrances and Q2 should be meaningfully better. On Amazon, management said the channel is growing week over week, bringing in younger and more affluent new-to-brand consumers, and is a controlled complement rather than a replacement for owned channels. On tariffs and promotions, the company said its full-year guide assumes tariffs and inflation are roughly neutral year over year, while promotions will stay broadly similar to last year rather than being sharply reduced.
Management cited multiple early proof points that the strategy is working, including double-digit AUR and SKU productivity on new soaps, improving conversion among new digital consumers, strong Amazon growth, and a 20% increase in White Barn Neutrals in Q2 versus last year. The company also pointed to store navigation changes, a new website, international growth, and a refreshed product pipeline as catalysts that could become more visible later in 2026 and into 2027.
Underlying demand is still pressured, with body care down mid-teens and management explicitly saying it is not calling a near-term inflection in sales. Gross margin remains under pressure from tariffs, inflation, crude oil and product investments, while Q2 guidance calls for another year-over-year sales decline and lower gross margin than Q1. The CFO transition adds execution risk, even though the company said the finance team and interim CFO provide continuity.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 94.1%
- Shares Outstanding
- 201.56M
- Float Shares
- 189.71M
of shares held by institutions
494 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for BBWI, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Ro KhannaHouse · CA17 | Sell | Jan 29, 26 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Sep 9, 24 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Nov 3, 23 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Aug 3, 23 | Filing → |
| Ro KhannaHouse · CA17 | Buy | May 19, 23 | Filing → |
| Susie LeeHouse · NV03 | Sell | Nov 30, 22 | Filing → |
| Ro KhannaHouse · CA17 | Sell | May 10, 22 | Filing → |
| Ro KhannaHouse · CA17 | Sell | May 23, 22 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Apr 11, 22 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Apr 21, 22 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Jan 21, 22 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Jan 11, 22 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 26.03M | ▼ 502.25K |
| Fmr LLC | 21.04M | ▲ 154.98K |
| Blackrock, Inc. | 19.41M | ▲ 92.46K |
| Vanguard Capital Management LLC | 9.07M | ▼ 90.33K |
| D. E. Shaw & Co., Inc. | 7.73M | ▼ 1.78M |
| Aqr Capital Management LLC | 7.64M | ▼ 3.40M |
| State Street Corp | 7.14M | ▲ 202.55K |
| Alliancebernstein L.P. | 5.61M | ▼ 140.54K |
| Citadel Advisors LLC | 5.11M | ▲ 3.03M |
| American Century Companies Inc | 4.09M | ▼ 379.75K |
| Renaissance Technologies LLC | 4.00M | ▲ 1.27M |
| Geode Capital Management, LLC | 3.74M | ▼ 222.08K |
Held by 426 ETFs
Biggest fund positions in BBWI by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 10, 26 | Aber Ann | other | 12,940 |
| Jul 20, 26 | Aber Ann | other | 0 |
| Jun 11, 26 | Voskuil Steven E | other | 7,970 |
| Jun 11, 26 | Rajlin Juan | other | 7,970 |
| Jun 11, 26 | Symancyk James Kevin | other | 7,970 |
| Jun 11, 26 | Lee Danielle M. | other | 7,970 |
| Jun 11, 26 | STEINOUR STEPHEN D | other | 7,970 |
| Jun 11, 26 | Hondal Francis | other | 7,970 |
| Jun 11, 26 | Nash Sarah E | other | 13,284 |
| Jun 11, 26 | Brady Lucy | other | 7,970 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our BBWI coverage
Recent articles, reports, and earnings notes.

The consumer is not breaking, but the stock market is done rewarding weak retailers for surviving
May retail sales were strong enough to keep the consumer alive as a macro story, but that does not make retail a broad buy again. The market is shifting into a tougher phase where execution, share gains, and credible turnarounds still work, while weaker discretionary names no longer get rerated just for hanging on.

Retail resilience is becoming a quality trade, not a consumer-wide bull case
May retail sales were strong enough to keep the consumer debate alive, but the stock market is already telling a narrower story. Spending is holding up, yet the gains are concentrating in value leaders, better operators, and selective turnarounds rather than lifting consumer discretionary as a single macro trade.

The consumer is not cracking evenly, and that matters more than the headline slowdown
This week’s ugly retail tape is real, but the market is making a mistake if it reads weak mid-tier apparel demand as proof of a universal consumer collapse. The better read is a bifurcated consumer: value and selective affluent spending are still working, while the middle of discretionary is getting squeezed.
Want a deeper read on BBWI?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Abercrombie & Fitch, America Movil, Bath & Body Works, Duolingo, Gorilla Technology, Lumentum Holdings, Micron Technology, Tapestry,and More
247wallst.com · Aug 18
Bath & Body Works, Inc. $BBWI Shares Purchased by Bank of America Corp DE
defenseworld.net · Aug 14
Bath & Body Works to Report Second Quarter Results on August 26, 2026
globenewswire.com · Aug 12
Bath & Body Works Declares Cash Dividend
globenewswire.com · Aug 7
Will Bath & Body Works (BBWI) Beat Estimates Again in Its Next Earnings Report?
zacks.com · Aug 4
Bath & Body Works: A Value Opportunity, Not A Value Trap
seekingalpha.com · Jul 28
Bath & Body Works Expands Global Footprint With Entry Into Brazil
globenewswire.com · Jul 16
Five Below's Strategic Investments Strengthen Future Growth Potential
zacks.com · Jul 15
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.